Valuation: Getinge AB

Market Cap 67.33B 6.71B 5.96B 5.57B 5.08B 9.54B 646B 9.68B 26.08B 329B 25.16B 24.62B 1,068B P/E 2026 *
21.3x
P/E 2027 * 19x
Enterprise Value 75.57B 7.53B 6.69B 6.25B 5.7B 10.71B 725B 10.86B 29.27B 370B 28.24B 27.63B 1,198B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.96x
Free-Float
79.13%
Yield 2026 *
2.1%
Yield 2027 * 2.29%
1 day+11.16%
1 month+11.16%
3 months+24.69%
6 months+7.62%
Current year+13.12%
Current year 20.05
Extreme 20.05
25
1 year 20.05
Extreme 20.05
25
3 years 15.62
Extreme 15.62
25
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+11.16%-.--% - - 6.77B
-2.17%-6.57%-27.81%-0.17% 171B
+0.17%-3.20%-9.24%+10.31% 110B
-0.88%-0.16%-26.16%-0.11% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.80%-0.88%+72.13% 57.3B
-0.52%-2.44%-4.86%-31.12% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%-0.82%-18.96%+18.41% 41.14B
-0.07%-1.71%+28.15%-7.58% 32.56B
Average +1.56%-1.46%-9.81%+12.06% 77B
Weighted average by Cap. +0.54%-2.07%-16.38%+9.01%

Financials

2026 *2027 *
Net sales 35.28B 3.52B 3.13B 2.92B 2.66B 5B 338B 5.07B 13.67B 173B 13.19B 12.9B 560B 37.33B 3.72B 3.31B 3.09B 2.82B 5.29B 358B 5.37B 14.46B 183B 13.95B 13.65B 592B
Net income 3.17B 316M 281M 262M 239M 449M 30.41B 456M 1.23B 15.52B 1.19B 1.16B 50.3B 3.56B 355M 315M 295M 269M 504M 34.13B 512M 1.38B 17.42B 1.33B 1.3B 56.46B
Net Debt 8.24B 822M 730M 682M 622M 1.17B 79.01B 1.18B 3.19B 40.32B 3.08B 3.01B 131B 6.01B 599M 532M 497M 454M 852M 57.63B 864M 2.33B 29.41B 2.25B 2.2B 95.32B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
247.20SEK
Average target price
251.70SEK
Spread / Average Target
+1.82%

Quarterly revenue - Rate of surprise